Show simple item record

dc.contributor.authorStraka, C
dc.contributor.authorPettengell, Ruth
dc.contributor.authorPielmeier, A
dc.contributor.authorCross, Michael A
dc.contributor.authorEmmerich, B
dc.contributor.authorCrowther, Derek
dc.contributor.authorTesta, Nydia G
dc.contributor.authorDexter, T Michael
dc.date.accessioned2010-04-26T10:04:46Z
dc.date.available2010-04-26T10:04:46Z
dc.date.issued1994
dc.identifier.citationA reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphoma. 1994, 5 Suppl 1:79-84 Ann. Oncol.en
dc.identifier.issn0923-7534
dc.identifier.pmid8172824
dc.identifier.doi10.1093/annonc/5.suppl_1.S79
dc.identifier.urihttp://hdl.handle.net/10541/97346
dc.description.abstractWe report a reliable approach for sequencing lymphoma-specific CDRIII regions. CDRIII regions present in DNA prepared from routinely fixed and paraffin-embedded diagnostic lymph node material were amplified by the use of consensus VH and JH primers via PCR. PCR products were subcloned directly, without purification or modification of PCR fragments. Only small amounts of miniprep plasmid DNA of recombinant clones were required for cycle sequencing, resulting in autoradiograms of high quality. The easy and reproducible method which we describe has enabled us to determine the lymphoma-specific CDRIII region in 7/11 high-grade non-Hodgkin's lymphomas as well as in 3/3 cases of ALL and 1/1 case of a centroblastic/centrocytic lymphoma. The obtained sequence data can serve to generate lymphoma-specific oligonucleotides, which then can be used as PCR primers or hybridization probes for the detection of minimal residual disease in individual patients.
dc.language.isoenen
dc.subject.meshBase Sequence
dc.subject.meshCloning, Molecular
dc.subject.meshHumans
dc.subject.meshImmunoglobulin Variable Region
dc.subject.meshLymphoma, B-Cell
dc.subject.meshMolecular Sequence Data
dc.subject.meshReproducibility of Results
dc.titleA reliable approach for sequencing clone-specific CDRIII regions in B-cell lymphoma.en
dc.typeArticleen
dc.contributor.departmentDepartment of Experimental Haematology, C.R.C. Paterson Institute for Cancer Research, Manchester, UK.en
dc.identifier.journalAnnals of Oncologyen
html.description.abstractWe report a reliable approach for sequencing lymphoma-specific CDRIII regions. CDRIII regions present in DNA prepared from routinely fixed and paraffin-embedded diagnostic lymph node material were amplified by the use of consensus VH and JH primers via PCR. PCR products were subcloned directly, without purification or modification of PCR fragments. Only small amounts of miniprep plasmid DNA of recombinant clones were required for cycle sequencing, resulting in autoradiograms of high quality. The easy and reproducible method which we describe has enabled us to determine the lymphoma-specific CDRIII region in 7/11 high-grade non-Hodgkin's lymphomas as well as in 3/3 cases of ALL and 1/1 case of a centroblastic/centrocytic lymphoma. The obtained sequence data can serve to generate lymphoma-specific oligonucleotides, which then can be used as PCR primers or hybridization probes for the detection of minimal residual disease in individual patients.


This item appears in the following Collection(s)

Show simple item record